Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Oncotarget|March 24, 2018
Reprogrammed lipid metabolism in bladder cancer with cisplatin resistanceMin Young Lee, Austin Yeon, Muhammad Shahid, et al.Cell Cycle (Georgetown, Tex.)|December 12, 2018
Centromere protein F (CENPF), a microtubule binding protein, modulates cancer metabolism by regulating pyruvate kinase M2 phosphorylation signalingMuhammad Shahid, Min Young Lee, Honit Piplani, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2021
Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor ImmunityYanping Wang, Sungyong You, Shengchen Su, et al.International Journal of Medical Sciences|August 17, 2021
Alendronate-induced Perturbation of the Bone Proteome and Microenvironmental PathophysiologyJayoung Kim, Austin Yeon, Sarah J Parker, et al.Scientific Reports|March 16, 2018
Alpha-oxoglutarate inhibits the proliferation of immortalized normal bladder epithelial cells via an epigenetic switch involving ARID1AMuhammad Shahid, Nicole Gull, Austin Yeon, et al.Scientific Reports|April 18, 2018
Author Correction: Alpha-oxoglutarate inhibits the proliferation of immortalized normal bladder epithelial cells via an epigenetic switch involving ARID1AMuhammad Shahid, Nicole Gull, Austin Yeon, et al.Cancer Letters|August 27, 2018
Integrated proteomic and phosphoproteomic analyses of cisplatin-sensitive and resistant bladder cancer cells reveal CDK2 network as a key therapeutic targetJae Hun Jung, Sungyong You, Jae Won Oh, et al.Pageof 2